Exporting Pharmaceutical Products to Brazil
Md. Joynal Abdin
Founder & Chief Executive Officer, Trade & Investment Bangladesh (T&IB)
Editor, T&IB Business Directory; Executive Director, Online Training Academy (OTA)
Secretary General, Brazil Bangladesh Chamber of Commerce & Industry (BBCCI)
Brazil is the largest pharmaceutical market in Latin America and consistently ranks among the top global medicine-consuming nations. With a population exceeding 200 million people, a universal public healthcare system known as SUS (Sistema Único de Saúde), and a rapidly expanding private healthcare segment, Brazil offers substantial and sustained demand for both essential and specialty medicines. Generic medicines represent a significant share of Brazil’s pharmaceutical consumption, creating space for cost-competitive, high-quality manufacturers capable of meeting strict regulatory standards.
Bangladesh’s pharmaceutical industry has evolved into one of the most technologically advanced sectors in the country’s manufacturing landscape. The country now exports pharmaceutical products to more than 150 countries, supported by WHO-GMP compliant facilities, US FDA, UK MHRA, TGA, and other international accreditations held by leading companies. With growing export earnings and rising global confidence in Bangladeshi generics, Brazil represents a high-value, high-compliance market where disciplined exporters can build long-term commercial success.
However, exporting pharmaceuticals to Brazil requires deep regulatory preparation, careful partner selection, tax planning, and long-term strategic commitment.
Prior Preparations to Export Pharmaceutical Products to Brazil
Regulatory Readiness and ANVISA Compliance
The cornerstone of market entry into Brazil is compliance with ANVISA, the Brazilian Health Regulatory Agency. Brazil does not treat pharmaceuticals as ordinary commercial goods; they are strictly regulated, and every imported product must follow registration, inspection, and approval pathways.
Before initiating discussions with Brazilian importers, Bangladeshi manufacturers must ensure that their manufacturing facilities meet international GMP standards aligned with ANVISA expectations. Although ANVISA may recognize certain foreign inspections in specific cases, Brazilian authorities maintain independent regulatory oversight and documentation requirements.
Manufacturers must prepare complete technical dossiers including product composition, manufacturing process validation, stability data under required climatic conditions, quality control methods, Certificates of Analysis, pharmacovigilance systems, and packaging specifications. In Brazil, product registration is typically handled by a locally licensed Marketing Authorization Holder, meaning that the Brazilian partner must have the legal authority to register and commercialize the product. Therefore, regulatory alignment between exporter and importer is essential from the beginning.
Product Selection Strategy
Not all products are equally viable for Brazil. The market is highly competitive in common primary care molecules, especially in generic oral solids. Exporters should evaluate therapeutic segments where they have competitive pricing advantage, differentiated dosage forms, injectables, oncology products, hormone preparations, specialized hospital products, or niche generics.
A successful strategy often begins with a limited, well-prepared product portfolio rather than an overly broad catalog. Concentrated effort on fewer molecules with strong documentation and pricing feasibility increases the probability of registration success.
Packaging and Portuguese Labeling
Brazil requires strict labeling in Portuguese. Carton artwork, patient information leaflets, and product inserts must follow regulatory formatting and language requirements. Exporters must allocate sufficient time for artwork adaptation, regulatory review, and printing validation.
Supply Chain and Quality Assurance Systems
Brazilian partners prioritize consistency. Manufacturers must demonstrate reliable production planning, validated processes, data integrity systems, and effective pharmacovigilance mechanisms. Export to Brazil should be supported by structured quality agreements between manufacturer and importer covering complaint handling, batch recalls, retention samples, and stability commitments.
Import Duty and Other Taxes on Importing Pharmaceutical Products into Brazil
Understanding Brazil’s tax structure is critical for commercial viability. Brazil operates a multi-layered tax system, and imported pharmaceutical products are subject to several federal and state-level taxes. These significantly influence landed cost and final pricing.
Import Duty (II – Imposto de Importação)
Import Duty varies according to the Mercosur Common External Tariff (CET). Many finished pharmaceutical products fall under HS Chapter 30. Depending on classification, Import Duty typically ranges between 0% and 14%. Essential medicines may benefit from reduced or zero rates, particularly when listed under special tariff exemptions. However, classification accuracy is critical, as incorrect HS coding can alter tax exposure significantly.
IPI (Industrialized Products Tax)
IPI is a federal excise tax applied to industrialized goods, including pharmaceuticals. For many pharmaceutical products, the IPI rate is relatively low and may range between 0% and 15%, depending on product classification. Certain medicines may benefit from reduced rates or exemptions.
PIS and COFINS (Social Contribution Taxes)
Imported pharmaceuticals are subject to PIS (Programa de Integração Social) and COFINS (Contribuição para o Financiamento da Seguridade Social). For imports, these taxes are generally calculated on the customs value plus Import Duty. The combined rate for PIS/COFINS on imports is commonly around 9.65%, though specific categories may vary.
ICMS (State VAT)
ICMS is a state-level value-added tax applied to circulation of goods. Rates differ by Brazilian state, typically ranging from 12% to 18%. ICMS significantly impacts final market pricing and must be calculated carefully in partnership with the Brazilian importer.
AFRMM (Additional Freight for Merchant Marine Renewal)
For goods transported by sea, AFRMM may apply at 25% of international ocean freight cost. This additional charge affects shipping cost calculations and must be considered when structuring CIF pricing.
Because of this layered tax structure, exporters must build a comprehensive landed-cost model in cooperation with their Brazilian distributor before finalizing pricing. Transparent tax modeling prevents commercial losses and ensures sustainable partnerships.
Top 25 Pharmaceutical Exporters in Bangladesh
Below is an enriched overview of leading Bangladeshi pharmaceutical manufacturers with international orientation. These companies possess significant manufacturing strength and export experience, though Brazil-specific readiness must be evaluated individually.
1. Square Pharmaceuticals PLC
Website: https://www.squarepharma.com.bd/
Square Pharmaceuticals is the largest pharmaceutical manufacturer in Bangladesh and one of the most technologically advanced. The company operates multiple WHO-GMP certified facilities and exports to numerous regulated and semi-regulated markets. With a diversified portfolio covering antibiotics, cardiovascular drugs, anti-diabetics, injectables, and specialty products, Square maintains strong production scale, advanced quality control laboratories, and structured global business development operations.
2. Incepta Pharmaceuticals Ltd.
Website: https://www.inceptapharma.com/
Incepta is known for its robust manufacturing infrastructure and technological advancement, including sterile injectables, vaccines, inhalation products, and biosimilar initiatives. The company has invested significantly in high-value dosage forms and maintains growing export networks across Asia, Africa, and beyond.
3. Beximco Pharmaceuticals PLC
Website: https://beximcopharma.com/
Beximco Pharmaceuticals is internationally recognized for exporting to highly regulated markets. It operates advanced manufacturing facilities and maintains a structured regulatory affairs team experienced in dossier submissions. Its product portfolio spans a wide therapeutic spectrum including cardiovascular, respiratory, oncology, and biologics-related lines.
4. Renata PLC
Website: https://renata-ltd.com/
Renata PLC combines strong domestic brand presence with expanding export operations. The company focuses on quality consistency, advanced formulations, and specialized dosage forms. Its disciplined manufacturing practices make it a credible supplier for compliance-heavy markets.
5. Eskayef Pharmaceuticals Ltd. (SK+F)
Website: https://www.skfbd.com/
Eskayef is a leading Bangladeshi manufacturer emphasizing quality excellence and global standards. With sophisticated production units and international certifications, SK+F produces high-quality generics and sterile products suitable for structured export programs.
6. The ACME Laboratories Ltd.
Website: https://www.acmeglobal.com/
ACME operates diversified pharmaceutical manufacturing plants and exports a wide range of finished formulations. The company has a growing footprint in global markets and invests in research-driven product development.
7. ACI Pharmaceuticals Ltd.
Website: https://www.acipharma.net/
ACI Pharmaceuticals is part of the ACI conglomerate and maintains strong corporate governance. It produces a broad range of generics and maintains expanding export operations supported by structured quality systems.
8. Opsonin Pharma Ltd.
Website: https://www.opsonin-pharma.com/
Opsonin has decades of experience in pharmaceutical manufacturing and exports. Its diversified therapeutic portfolio and expanding production capacity support international business development.
9. Healthcare Pharmaceuticals Ltd.
Website: https://www.hplbd.com/
Healthcare Pharmaceuticals is recognized for wide therapeutic coverage and disciplined manufacturing systems. The company has expanded its export footprint steadily across emerging markets.
10. Aristopharma Ltd.
Website: https://www.aristopharma.com/
Aristopharma has established strong domestic brands and maintains growing export operations. The company invests in product innovation and international quality compliance.
11. Beacon Pharmaceuticals PLC
Website: https://beaconpharma.com.bd/
Beacon Pharmaceuticals is particularly known for oncology and high-technology dosage forms. Its specialized facilities and advanced research capabilities support niche export markets.
12. Drug International Ltd.
Website: https://drug-international.com/
Drug International is a long-standing manufacturer with structured export initiatives and diversified dosage forms.
13. Popular Pharmaceuticals PLC
Website: http://www.popular-pharma.com/
Popular Pharmaceuticals combines strong domestic presence with export ambitions, supported by modern production facilities and brand development initiatives.
14. Navana Pharmaceuticals PLC
Website: https://navanapharma.com/
Navana Pharma is expanding rapidly, with modern manufacturing plants and growing international outreach.
15. Orion Pharma Ltd.
Website: https://orionpharmabd.com/
Orion Pharma has long manufacturing experience and maintains diversified product lines suitable for multi-market export expansion.
16. The IBN SINA Pharmaceutical Industry PLC
Website: https://www.ibnsinapharma.com/
IBN SINA integrates pharmaceutical production with broader healthcare operations and maintains growing export networks.
17. Ziska Pharmaceuticals Ltd.
Website: https://www.ziskapharma.com/
Ziska emphasizes product development, innovation, and expanding export capabilities.
18. Nuvista Pharma Ltd.
Website: https://nuvistapharma.com/
Nuvista operates with a structured corporate footprint and maintains export engagement across selected regions.
19. UniMed UniHealth Pharmaceuticals Ltd.
Website: https://unimedunihealth.com/
UniMed UniHealth combines pharmaceutical and healthcare service integration, supporting long-term export planning.
20. NIPRO JMI Pharma Ltd.
Website: https://www.niprojmipharma.com/
A joint venture with Japanese collaboration, NIPRO JMI emphasizes cGMP discipline and sterile manufacturing excellence.
21. Apex Pharma Ltd.
Website: https://www.apexpharmabd.com/
Apex Pharma is a growing manufacturer with focused production units and expanding export presence.
22. General Pharmaceuticals Ltd.
Website: https://generalpharma.com/
General Pharmaceuticals integrates formulation and API strengths and maintains expanding international operations.
23. Biopharma Ltd.
Website: https://www.biopharmabd.com/
Biopharma operates diversified pharmaceutical manufacturing lines and continues export expansion efforts.
24. Radiant Pharmaceuticals Ltd.
Website: https://www.radiantpharmabd.com/
Radiant Pharmaceuticals is recognized for strong brand presence and growing export initiatives.
25. Radiant Nutraceuticals Ltd.
Website: https://www.radiantnutrabd.com/
Radiant Nutraceuticals extends into regulated health supplement segments, complementing pharmaceutical export ecosystems.
Brazil Bangladesh Chamber of Commerce & Industry (BBCCI) Assistance
For pharmaceutical exporters, success in Brazil depends not only on compliance but also on trusted institutional networks. The Brazil Bangladesh Chamber of Commerce & Industry facilitates structured B2B engagement, introductions to Brazilian chambers and sectoral associations, and coordination with licensed distributors and marketing authorization holders.
BBCCI supports exporters in identifying credible partners, organizing trade missions, arranging meetings in São Paulo and other commercial centers, and bridging language and regulatory communication gaps. Through institutional collaboration, exporters can reduce entry risk and accelerate strategic positioning in Brazil.
Become a Member of BBCCI
Membership in BBCCI strengthens credibility and opens access to bilateral business facilitation services. Members benefit from organized trade delegations, structured matchmaking, policy insights, and institutional representation in Brazil-focused initiatives. For pharmaceutical manufacturers seeking structured and sustainable expansion into Brazil, BBCCI membership serves as a strategic gateway.
Closing Remarks
Exporting pharmaceutical products to Brazil is a sophisticated endeavor requiring regulatory excellence, financial planning, tax understanding, and disciplined partnership management. While Brazil’s layered tax system and regulatory framework may appear complex, they also create entry barriers that reward serious and well-prepared manufacturers. Bangladesh’s pharmaceutical industry has reached a stage where technical capability, production scale, and quality discipline can compete globally. With strategic planning, proper tax modeling, and institutional support, Brazil can evolve from a challenging destination into a long-term strategic pillar for Bangladeshi pharmaceutical exporters.